Intellectual Property Services Overview

Insights Resources
Healthcare Life Sciences & Pharmacy

Related Insights

Article

Articles

03/12/2026

PBMs Are Targeting Alabama Hospitals with Discriminatory Networks: What 340B Covered Entities Need to Know
Newscat

News

03/11/2026

A.J. Barbarito Featured in MedCity News: “It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?”
Article

Articles

03/11/2026

Plan Sponsor Alert: Recent ERISA Decisions Increase Employer Liability Risk for Excessive Fees Paid to Vendors, Brokers, and Service Providers, Including PBMs
Article

Articles

03/10/2026

Arizona Board of Pharmacy Amendments: Enforcement Caps, Board Continuation, and Ownership Changes
Article

Articles

03/10/2026

The Peptide Landscape Is Shifting: What Secretary Kennedy’s Joe Rogan Interview Could Mean for the Compounding Industry
Article

Articles

03/09/2026

From Crackdown to Collaboration: FDA Warning Letters and the Hims-Novo Nordisk Deal Signal a New Era for Compounded GLP-1 Drugs
Article

Articles

03/09/2026

FDA Crackdown on Telehealth Advertising: What Your Company Needs to Know About Compounded Drug Marketing Compliance
Article

Articles

03/09/2026

Down by the Bayou: How Louisiana’s $45 Million Settlement with Caremark Foreshadows Heightened Scrutiny for PBMs in the State